Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Debt / NOTE 2.500% 6/0
-
Market price (% of par)
-
92.34%
-
Total 13F principal
-
$635,170,914
-
Principal change
-
-$11,027,586
-
Total reported market value
-
$587,520,410
-
Number of holders
-
46
-
Value change
-
-$13,170,448
-
Number of buys
-
23
-
Number of sells
-
21
Institutional Holders of HAEMONETICS CORP MASS - NOTE 2.500% 6/0 as of Q3 2025
As of 30 Sep 2025,
HAEMONETICS CORP MASS - NOTE 2.500% 6/0 was held by
46 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$635,170,914
in principal (par value) of the bond.
The largest 10 bondholders included
Linden Advisors LP, CAMDEN ASSET MANAGEMENT L P /CA, Invesco Ltd., WOLVERINE ASSET MANAGEMENT LLC, FRANKLIN RESOURCES INC, ZAZOVE ASSOCIATES LLC, ADVENT CAPITAL MANAGEMENT /DE/, Wellesley Asset Management, Calamos Advisors LLC, and WELLS FARGO & COMPANY/MN.
This page lists
46
institutional bondholders reporting positions
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.